Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters

Database
Language
Publication year range
1.
J Nutr Biochem ; 97: 108808, 2021 11.
Article in English | MEDLINE | ID: mdl-34186211

ABSTRACT

Studies in mice using germfree animals as controls for microbial colonization have shown that the gut microbiome mediates diet-induced obesity. Such studies use diets rich in saturated fat, however, Western diets in the United States America are enriched in soybean oil, composed of unsaturated fatty acids, either linoleic or oleic acid. Here, we addressed whether the microbiome is a variable in fat metabolism in mice on a soybean oil diet. We used conventionally-raised, low-germ, and germfree mice fed for 10 weeks diets either high or low in high-linoleic-acid soybean oil as the sole source of fat. Conventional and germfree mice gained relative fat weight and all mice consumed more calories on the high fat vs. low fat soybean oil diet. Plasma fatty acid levels were generally dependent on diet, with microbial colonization status affecting iso-C18:0, C20:3n-6, C14:0, and C15:0 levels. Colonization status, but not diet, impacted levels of liver sphingolipids including ceramides, sphingomyelins, and sphinganine. Our results confirm that absorbed fatty acids are mainly a reflection of the diet and that microbial colonization influences liver sphingolipid pools regardless of diet.


Subject(s)
Diet, Western , Fatty Acids/blood , Gastrointestinal Microbiome/physiology , Liver/metabolism , Soybean Oil , Sphingolipids/metabolism , Adipose Tissue , Animals , Body Weight , Feces/microbiology , Germ-Free Life , Male , Mice , Mice, Inbred C57BL
2.
Elife ; 72018 03 27.
Article in English | MEDLINE | ID: mdl-29580380

ABSTRACT

Over the past century, soybean oil (SBO) consumption in the United States increased dramatically. The main SBO fatty acid, linoleic acid (18:2), inhibits in vitro the growth of lactobacilli, beneficial members of the small intestinal microbiota. Human-associated lactobacilli have declined in prevalence in Western microbiomes, but how dietary changes may have impacted their ecology is unclear. Here, we compared the in vitro and in vivo effects of 18:2 on Lactobacillus reuteri and L. johnsonii. Directed evolution in vitro in both species led to strong 18:2 resistance with mutations in genes for lipid biosynthesis, acid stress, and the cell membrane or wall. Small-intestinal Lactobacillus populations in mice were unaffected by chronic and acute 18:2 exposure, yet harbored both 18:2- sensitive and resistant strains. This work shows that extant small intestinal lactobacilli are protected from toxic dietary components via the gut environment as well as their own capacity to evolve resistance.


Subject(s)
Gastrointestinal Microbiome/drug effects , Intestine, Small/microbiology , Lactobacillus johnsonii/drug effects , Limosilactobacillus reuteri/drug effects , Linoleic Acid/toxicity , Soybean Oil/toxicity , Animals , Drug Resistance, Bacterial , Lactobacillus johnsonii/growth & development , Limosilactobacillus reuteri/growth & development , Mice , Mutation , Selection, Genetic
SELECTION OF CITATIONS
SEARCH DETAIL